According to our (Global Info Research) latest study, the global Non-invasive Intracranial Pressure (ICP) Monitoring Devices market size was valued at US$ 124 million in 2025 and is forecast to a readjusted size of US$ 187 million by 2032 with a CAGR of 6.0% during review period.
Non-invasive intracranial pressure (ICP) monitoring devices assess ICP-related dynamics without skull penetration or catheter placement by acquiring external or physiological surrogate signals and performing onboard processing, waveform quality control, feature extraction, and interpretation. Typical architectures combine a sensing front end (sensor/probe/adhesive fixtures) with an analysis console (algorithms, display/alarms, data handling, and connectivity). Compared with invasive monitoring, outputs are more often trends, surrogate waveforms, and risk-oriented metrics rather than catheter-equivalent absolute ICP values. The primary value proposition is scalable, repeatable bedside assessment with lower operational and complication burdens, supporting emergency screening, transport and ICU adjunct use, and follow-up in patients who are not candidates for invasive access. In 2025, global Non-invasive Intracranial Pressure (ICP) Monitoring Devices production reached approximately 12 K Units and price is about 10 K USD/Unit.The average gross profit margin of this product is 50%.
Neurocritical and emergency-care workflows increasingly demand earlier detection, faster stratification, and reproducible decision pathways for intracranial risk. Non-invasive ICP devices can provide lower-risk intracranial dynamic signals for emergency screening, in-hospital transport, resource-limited settings, and selected high-risk populations, helping clinicians coordinate imaging prioritization and monitoring escalation. At the same time, multimodal brain monitoring elevates trend visibility and waveform morphology as actionable information, and some systems are positioned to monitor variation and compliance change via surrogate waveforms and parameters—creating an upgrade space that spans hardware, algorithms, quality control, and interoperable data handling. The key barriers are evidence closure and misuse risk. Surrogate-signal approaches are sensitive to anatomical variability, measurement-window constraints, operator dependence, posture changes, and motion artifacts—making repeatability within the same patient and generalizability across populations decisive commercialization hurdles. If trend or risk outputs are misinterpreted as catheter-equivalent absolute ICP, delayed or unnecessary interventions can occur; therefore, clear indication boundaries, interpretable outputs, and visible quality-control workflows are essential. Clinical practice discussions also emphasize that when absolute pressure is required for critical decisions, surrogate outputs should not be treated as direct substitutes for invasive reference monitoring. Demand is shifting from “can it measure” to “can it be operationalized, user-friendly, and auditable.” Emergency care prioritizes rapid bedside screening and consistent short-interval rechecks; critical-care teams value stable continuous trends, readable surrogate waveforms, event annotation and playback, and efficient alignment with pupillary assessment, ultrasound flow proxies, ocular metrics, and imaging follow-up. Longitudinal follow-up increasingly requires cross-visit comparability and standardized training, pushing products toward lower operator dependence with built-in quality control and algorithm-assisted interpretation, alongside stronger interoperability with hospital data platforms. Upstream competitiveness is defined by the sensing and acquisition chain, fixation and skin-contact components, and the software/algorithm plus compliance framework. Skull-deformation and surrogate-waveform systems depend on high-sensitivity sensors, low-noise front-end electronics, electromagnetic robustness, and stable fixation, coupled with algorithms that derive compliance-related waveform features for interpretation. Ocular and ultrasound vascular-proxy approaches rely more on probe/optical consistency and standardized acquisition workflows to reduce operator-driven variance. Medical-grade skin-contact materials, disinfection durability validation, cybersecurity, and software lifecycle governance increasingly set the ceiling for scalable quality and repeatable deployment.
This report is a detailed and comprehensive analysis for global Non-invasive Intracranial Pressure (ICP) Monitoring Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-invasive Intracranial Pressure (ICP) Monitoring Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Non-invasive Intracranial Pressure (ICP) Monitoring Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Non-invasive Intracranial Pressure (ICP) Monitoring Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Non-invasive Intracranial Pressure (ICP) Monitoring Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-invasive Intracranial Pressure (ICP) Monitoring Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-invasive Intracranial Pressure (ICP) Monitoring Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, HaiWeiKang, HeadSense Medical, Vittamed, Comen, PrimaNova, TALEND MEDICAL, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-invasive Intracranial Pressure (ICP) Monitoring Devices market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sound Signal Monitoring
Blood Flow Signal Monitoring
Market segment by Monitoring Principle
Transcranial Doppler (TCD)-based Non-invasive ICP Devices
Optic Nerve Sheath Diameter (ONSD)-based Non-invasive ICP Devices
Market segment by Signal Acquisition Method
Ultrasound-based Non-invasive ICP Monitoring Devices
Physiological Signal Modeling-based Non-invasive ICP Devices
Market segment by Device Form Factor
Portable Non-invasive ICP Monitoring Devices
Bedside Non-invasive ICP Monitoring Devices
Market segment by Application
Traumatic Brain Injury
Intracerebral Hemorrhage
Meningitis
Subarachnoid Hemorrhage
Others
Major players covered
Medtronic
HaiWeiKang
HeadSense Medical
Vittamed
Comen
PrimaNova
TALEND MEDICAL
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-invasive Intracranial Pressure (ICP) Monitoring Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-invasive Intracranial Pressure (ICP) Monitoring Devices, with price, sales quantity, revenue, and global market share of Non-invasive Intracranial Pressure (ICP) Monitoring Devices from 2021 to 2026.
Chapter 3, the Non-invasive Intracranial Pressure (ICP) Monitoring Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-invasive Intracranial Pressure (ICP) Monitoring Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-invasive Intracranial Pressure (ICP) Monitoring Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-invasive Intracranial Pressure (ICP) Monitoring Devices.
Chapter 14 and 15, to describe Non-invasive Intracranial Pressure (ICP) Monitoring Devices sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Non-invasive Intracranial Pressure (ICP) Monitoring Devices. Industry analysis & Market Report on Non-invasive Intracranial Pressure (ICP) Monitoring Devices is a syndicated market report, published as Global Non-invasive Intracranial Pressure (ICP) Monitoring Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Non-invasive Intracranial Pressure (ICP) Monitoring Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.